• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer

    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    JBC Technologies

    LEMO USA Inc.

    Paragon Medical

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    JBC Technologies

    LEMO USA Inc.

    Paragon Medical

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    BioSig Announces Successful First-In-Human Use of PURE EP System

    Early results suggest improved cardiac signal detection and fidelity.

    BioSig Announces Successful First-In-Human Use of PURE EP System
    The PURE EP System. Image courtesy of BioSig Technologies.
    Related CONTENT
    • BioSig Technologies Expands its Engineering Team
    • BioSig Announces Successful First-In-Human Use of PURE EP System
    • Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott's MitraClip
    • Abbott's Alinity m Diagnostics System and Assays Gain CE Mark
    • Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half
    Globe Newswire04.11.19
    BioSig Technologies Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, has successfully conducted the first patient cases using PURE EP System, its U.S. Food and Drug Administration (FDA)-approved proprietary signal acquisition and processing technology. The first commercial use of the System was completed at the Texas Cardiac Arrhythmia Institute (TCAI) in Austin, Texas.
     
    The patient studies were conducted by Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., executive medical director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center.

    “With the use of the PURE EP System I was able to identify cardiac signals which were previously undetectable to me. I believe that the PURE EP System could change diagnostic and treatment strategies of arrhythmias, leading to more successful outcomes,” commented Dr. Natale.
     
    The PURE EP System was used during the standard studies on patients with persistent atrial fibrillation and conducted in parallel with Abbott’s EnSite Precision and Biosense Webster’s (Johnson & Johnson) CARTO cardiac mapping systems. The goal of the first commercial use of the technology was aimed at validating the System’s key value proposition elements and report on the overall user experience during the procedure.
     
    “We are highly encouraged by the first results reported by Dr. Natale and his team at this facility. A positive first-in-human experience is a major inflection point for our company and lays a strong foundation for our early commercialization efforts,” commented Kenneth L. Londoner, chairman and CEO of BioSig Technologies. “We are well positioned to deliver on our strategic goals for 2019 and look forward to the expansion of our evaluation efforts in the coming months.”

    The PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The PURE EP System aims to minimize noise and artifacts and acquire high-fidelity cardiac signals. Improving fidelity of acquired cardiac signals may potentially increase the diagnostic value of these signals, thereby possibly improving accuracy and efficiency of the EP studies and related procedures. The results of pre-clinical studies have been published in a number of journals, including The Journal of Innovations in Cardiac Rhythm Management.
     
    Located at St. David’s Medical Center in Austin, Texas, the Texas Cardiac Arrhythmia Institute is a recognized training, research and treatment facility dedicated solely to heart rhythm disorders. St. David’s is a state-of-the-science medical center with a medical support staff. Its robotics, magnetics and other advanced technologies complement the expertise of TCAI’s physicians. The Institute brings TCAI’s physicians and researchers together with St. David’s superior facilities to address even the most challenging arrhythmias.
     
    BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. Led by a management team and a veteran Board of Directors, BioSig Technologies is preparing to commercialize its PURE EP System. The technology has been developed to address an unmet need in a large and growing market.
     
    The company’s first product, PURE EP System, is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision-making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, atrial fibrillation and ventricular tachycardia. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP System in August 2018.
    Related Searches
    • diagnostic
    • pure ep system
    • development
    • standard
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    BioSig Technologies Expands its Engineering Team BioSig Technologies Expands its Engineering Team
    BioSig Announces Successful First-In-Human Use of PURE EP System BioSig Announces Successful First-In-Human Use of PURE EP System
    Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott's MitraClip
    Abbott Abbott's Alinity m Diagnostics System and Assays Gain CE Mark
    Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half
    FDA Approves Expanded Indication for Abbott FDA Approves Expanded Indication for Abbott's MitraClip
    Abbott Launches Reformulated BinaxNOW Rapid Influenza Test Abbott Launches Reformulated BinaxNOW Rapid Influenza Test
    Novo Nordisk Digital Insulin Pen Now Compatible with Abbott Novo Nordisk Digital Insulin Pen Now Compatible with Abbott's FreeStyle Libre CGM
    Electrophysiology Expert Joins BioSig Technologies Management Team Electrophysiology Expert Joins BioSig Technologies Management Team
    FDA Approves Cardiva Medical FDA Approves Cardiva Medical's VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure
    BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
    Abbott to Acquire Cephea Valve Technologies Abbott to Acquire Cephea Valve Technologies
    Medical Leaders Join BioSig Clinical Advisory Board Medical Leaders Join BioSig Clinical Advisory Board
    BioSig Technologies Announces New Research Program With Mayo Clinic BioSig Technologies Announces New Research Program With Mayo Clinic

    Related Breaking News

    • BioSig Technologies Expands its Engineering Team

      BioSig Technologies Expands its Engineering Team

      New hire to drive R&D and manufacturing efforts.
      Globe Newswire 04.10.19

    • BioSig Announces Successful First-In-Human Use of PURE EP System

      BioSig Announces Successful First-In-Human Use of PURE EP System

      Early results suggest improved cardiac signal detection and fidelity.
      Globe Newswire 04.03.19

    • Cardiovascular | Surgical
      Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott

      Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott's MitraClip

      Treatment with MitraClip resulted in significant and sustained long-term quality-of-life improvements compared to medical therapy.
      Abbott Laboratories 03.19.19


    • Diagnostics
      Abbott

      Abbott's Alinity m Diagnostics System and Assays Gain CE Mark

      Alinity m will allow labs to meet the growing demand for infectious disease testing by offering increased efficiency and market-leading speed and accuracy.
      Abbott Laboratories 03.19.19

    • Cardiovascular
      Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half

      Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half

      Heart failure is among the top conditions that result in hospitalizations among people age 65 years and older.
      American College of Cardiology 03.18.19

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    Breaking News
    • The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    • Coloplast Launches New Catheter in the U.S.
    • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    • NAMSA Relaunches Medtech Outsourcing Solution
    • Rollomatic Inc. Welcomes Joe Kane as CEO
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Dr. Ranjini Murthy Joins Azelis Americas as SVP of Commercial and Digital Excellence
    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Berry Health Benefits Symposium Includes Panel on Dietary Supplements
    Coatings World

    Latest Breaking News From Coatings World

    EPS Launches New Acrylic DIrect-to-Metal Polymer
    Evonik, Partners Launch PlasCO₂ Project for C4 Chemicals Production
    Masco Corporation Reaches $5 Million Milestone in Grant Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Coloplast Launches New Catheter in the U.S.
    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    NAMSA Relaunches Medtech Outsourcing Solution
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer Revenues Soar to Record-Breaking $100B in 2022
    iuvo BioScience Appoints Industry Exec to Lead Lab Biz
    Seqens Opens Flagship R&D Center in Greater Boston
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    1Saves20 Launches Collection of Rinse-Free, Resource-Conscious Beauty Products
    U.S. Prestige Beauty Industry Sales Revenue Grew 15% in 2022
    Personal Care Market Forecasted to Grow at CAGR of 6.4% from 2022-2027
    Happi

    Latest Breaking News From Happi

    Nutricosmetics & Wellness Market Expected to Grow 5% by 2033
    Anastasia Beverly Hills Celebrates 25th Anniversary
    Henkel Honors Leading Suppliers During American Cleaning Institute Convention Week
    Ink World

    Latest Breaking News From Ink World

    International Paper Reports Full-Year, 4Q 2022 Results
    UFlex Exhibits Sustainable Printing, Packaging Solutions at Plast India 2023
    Early-Bird Registration Opens for Print UV 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FLAG achieves record membership in 2022
    AWA to host 23rd Global Release Liner Industry Conference & Exhibition
    Color-Logic certifies Ecofoil digital labestock for cut sheet printers
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ahlstrom Launches New Generation FluoroFree Technology
    Berry to Begin Production at India Healthcare Hub Early This Year
    FiltXPO to be Held in October
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    ODT's Most-Read Stories This Week—Jan. 28
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Textiles are Smarter with Durak SilverPro Conductive Threads
    Arkema Partners with Research Institute to Open Lab in Mulhouse, France
    Veridos to Become Majority Shareholder in NetSeT

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login